Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia
Open Access
- 13 July 2017
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 130 (2) , 205-213
Abstract
Key Points: Diffuse myocardial fibrosis is a common and novel mechanism of heart disease in SCA that can be detected noninvasively. Diffuse myocardial fibrosis is strongly associated with diastolic dysfunction in individuals with SCA.Keywords
This publication has 52 references indexed in Scilit:
- T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular HypertrophyCirculation: Cardiovascular Imaging, 2013
- Human non-contrast T1 values and correlation with histology in diffuse fibrosisHeart, 2013
- Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experienceJournal of Cardiovascular Magnetic Resonance, 2012
- Correlation of N-Terminal Fragment of B-type Natriuretic Peptide Levels with Clinical, Laboratory, and Echocardiographic Abnormalities in Children with Sickle Cell DiseaseThe Journal of Pediatrics, 2011
- Safety of gadolinium‐based contrast material in sickle cell diseaseJournal of Magnetic Resonance Imaging, 2011
- Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agentDrug Design, Development and Therapy, 2009
- Doppler‐defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three yearsBritish Journal of Haematology, 2009
- Right Atrial Volume Index in Chronic Systolic Heart Failure and PrognosisJACC: Cardiovascular Imaging, 2009
- Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell DiseaseJACC, 2007
- Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell DiseaseNew England Journal of Medicine, 2004